ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) moved up 5.8% and closed its last trading session at $25.34. This Medical Sector stock currently has the Market Capitalization of 2.87 Billion. The Average Volume for the stock is measured as 2.16 Million. The Stock has a 52-Week High of $43.3 and 52-Week Low of $16.64 following the dates, it touched its 52-Week High on Nov 4, 2015 and 52-Week Low on Feb 9, 2016. Currently, the Return on Assets value for the trailing twelve months is -60% with the Return on Equity and Return on Investment of -64.2% and 0% respectively. This firm currently has YTD (year to date) performance of -28.92 Percent which is not good. The Short Ratio for the stock is 8.67.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Price to Earnings (P/E) ratio is 0. EPS or Earning per Share stands at $-1.92. The TTM operating margin is 0 percent.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is due to report its Earnings on Thu 3 Nov (In 11 Days). The estimated EPS for the current quarter is said to be $-0.55. Following Earnings result, share price were DOWN 18 times out of last 27 Qtrs. The stock has reduced about -30.5% since it reported its last earnings. The Closing price of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) at Last Earnings was $36.48 as compared to the previous closing price of $23.95. The Predicted Move on the 7th day after ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) will release its earnings at about 9%.
By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) beats earnings by 8%, The Stock Missed Earnings 9 times and has met earnings 2 times.
We will discuss the past Quarters Earnings below:
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported its previous quarter on 08/04/2016 where it reported the Actual Earnings of $-0.63. The Closing price before the company posted its earnings was $36.48. The Stock surged on the very next day of earnings and maintained its stock price at $36.49 by showing a % change of 0.03 percent from its previous closing price. The Next Day Volume after Earnings was reported as 2.85 Million. On the 7th day After Earnings Report, the stock hit its share price as $31.87 by showing -12.64% decrease from the Stock price Before Earnings were reported.
On 05/05/2016, the stock reported the EPS of $-0.45 where Analysts were projecting the EPS to be $-0.42 showing a difference of $-0.03. Thus Surprise Factor was there with -7.1 percent. Before Earnings Announcement on 05/05/2016, the firm had its stock price of $27.05. And immediately on the next day after earnings announcement, the stock inclined 2.22% and closed its trading session at $27.65. On 7th Day after earnings release, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) surged to 2.81% from $27.05 to $27.81.
On 02/29/2016, Analysts were suspecting EPS of $-0.38/share where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported its Actual EPS of $-0.45. Thus showing a Surprise of -18.4 percent. The Closing Price of the stock before earnings was $18.73 while on the Next day the stock closed its trading session at $17.26 with a percentage change of -7.85% from the price of 18.73 before Earnings. The Stock Closing Price on the 7th day of earnings was $21.2.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinsons disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimers disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.